Skip to main content

Cemex Files 2025 Audited Results and Flags Key Impairment Risks Ahead of March Shareholder Vote

Tipranks - Thu Feb 26, 5:24PM CST

Claim 50% Off TipRanks Premium

Cemex SAB ( (CX) ) has issued an announcement.

On February 25, 2026, Cemex filed its Form 6-K announcing that its consolidated and separate financial statements for the years ended December 31, 2025, 2024, and 2023 are being submitted for shareholder approval at an Ordinary General Shareholders’ Meeting scheduled for March 26, 2026. The audited consolidated accounts, prepared under IFRS and reviewed by KPMG, highlight key audit areas including a $307 million goodwill impairment in the U.S. cash-generating units and the assessment of impairment indicators for a Colombian cement plant that is subject to ongoing legal proceedings, underscoring material judgment areas in the company’s asset valuations.

The most recent analyst rating on (CX) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Cemex SAB stock, see the CX Stock Forecast page.

Spark’s Take on CX Stock

According to Spark, TipRanks’ AI Analyst, CX is a Outperform.

The score is driven primarily by solid financial performance (profitability recovery, improved leverage, and positive free cash flow) and supportive earnings-call guidance around cost savings, margins, and free-cash-flow conversion. Technicals are mixed with neutral momentum and near-term consolidation, while valuation is middling with a low dividend yield.

To see Spark’s full report on CX stock, click here.

More about Cemex SAB

Cemex, S.A.B. de C.V. is a global building materials company based in Mexico, operating in the cement, ready-mix concrete, and aggregates industry. It serves infrastructure, commercial, and residential construction markets worldwide, with significant asset bases in the United States, Latin America, and other key regions.

Average Trading Volume: 6,361,273

Technical Sentiment Signal: Buy

Current Market Cap: $19.04B

Find detailed analytics on CX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.